Relationship of CP and AP
The Prevalence of Acute Pancreatitis Episodes Among Patients With Chronic Pancreatitis and the Associated Factors
1 other identifier
observational
1,022
0 countries
N/A
Brief Summary
The present study aimed to determine the prevalence of AP attacks before the diagnosis of CP and further identified the potential associated factors for AP episodes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2010
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2020
CompletedFirst Submitted
Initial submission to the registry
December 11, 2020
CompletedFirst Posted
Study publicly available on registry
December 17, 2020
CompletedDecember 17, 2020
December 1, 2020
5.9 years
December 11, 2020
December 15, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
the occurrence of acute pancreatitis
the presence and frequency of acute pancreatitis before diagnosis of CP
Baseline (before the diagnosis of CP)
Interventions
There was no intervention.
Eligibility Criteria
Consequent patients with a diagnosis of CP were enrolled between January 2010 to December 2015 after informed consents obtained.The diagnosis of CP was established based on the findings of computed tomography, magnetic resonance imaging, or endoscopic ultrasound, in accordance with the Asia-Pacific consensus.
You may qualify if:
- Consequent patients with a diagnosis of CP between January 2010 to December 2015
- informed consents provided
You may not qualify if:
- autoimmune pancreatitis (AIP)
- pancreatic cancer diagnosed within 2 years after the diagnosis of CP
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 11, 2020
First Posted
December 17, 2020
Study Start
January 1, 2010
Primary Completion
December 1, 2015
Study Completion
October 1, 2020
Last Updated
December 17, 2020
Record last verified: 2020-12